Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 1;34(3):114-118.
doi: 10.1097/MOL.0000000000000874. Epub 2023 Feb 22.

Nonalcoholic fatty liver disease: an update

Giorgio Bedogni  1   2 , Francesco Palmese  1   2 , Francesco Giuseppe Foschi  3
Affiliations
Review

Nonalcoholic fatty liver disease: an update

Giorgio Bedogni et al. Curr Opin Lipidol. .

Abstract

Purpose of review: We discuss two recent controversial issues in the research field of fatty liver: the proposal to replace nonalcoholic fatty liver disease (NAFLD) with metabolically associated fatty liver disease (MAFLD) and the suggestion to extend to primary care the noninvasive testing for liver fibrosis that was developed for secondary care.

Recent findings: There is preliminary evidence that MAFLD-only patients are at greater risk of fibrosis than NAFLD-only patients. There are a large number of false positives associated with the downshift of noninvasive testing for liver fibrosis from secondary to primary care.

Summary: More studies are needed to compare the MAFLD and NAFLD operational definitions. Noninvasive testing of liver fibrosis also needs further evaluation before it can be used in primary care or in the general population.

PubMed Disclaimer

References

    1. Eslam M, Sanyal AJ, George J. International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020; 158:1999.e1–2014.e1.
    1. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020; 73:202–209.
    1. Singh SP, Anirvan P, Reddy KR, et al. Nonalcoholic fatty liver disease: not time for an obituary just yet. J Hepatol 2021; 74:972–974.
    1. Younossi ZM, Rinella ME, Sanyal AJ, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology 2021; 73:1194–1198.
    1. Singh SP, Anirvan P, Khandelwal R, Satapathy SK. Nonalcoholic fatty liver disease (NAFLD) name change: Requiem or Reveille. J Clin Translat Hepatol 2021; 9:931–938.

MeSH terms